lcar-b38m car-t cell
Cell therapyexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Oct 2, 2015 (NCT03090659)
Timeline
Indications
Studied for
Mechanism of action
- BCMAImmunity, passive
BCMA immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- lcar-b38m car-t cell
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03758417 | Phase 2 | Jan 28, 2019 | GenScript, Johnson and Johnson |
| NCT03090659 | Phase 1/Phase 2 (Phase 2) | Oct 2, 2015 | GenScript |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| GenScript | For profit | 2 | 2 | 1 | 2015 |
| Johnson and Johnson | For profit | 1 | 0 | 1 | 2019 |
2 organizations
Page 1 / 1